NCT05247762Completed
Effect of Acupuncture on Visual Acuity and Visual Field in Patients With Primary Open-angle Glaucoma
Source: ClinicalTrials.gov · Last updated 10 Apr 2024
Brief summary (registry, in English)
The goal of this clinical trial is to test the therapeutic effect of acupuncture at the Jingming and the Qiuhou acupoints on the visual acuity and visual field in patients with primary open-angle glaucoma. Participants will get acupuncture or Wangbuliu Xingzi Paste (sham acupuncture) on both sides of the Jingming and the Qiuhou, once a week, once for 20 minutes, for 24 weeks. Researchers will compare acupuncture group and sham acupuncture group to see if the visual acuity, visual field, intraocular pressure, optic nerve fiber layer thickness, serum homocysteine concentration, and scores on the WHOQOL-REF (Taiwan version) scale would be improved.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 10 Feb 2022
- Start date
- 28 Feb 2022
- Primary completion date
- 30 Nov 2023
- Lead sponsor
- China Medical University Hospital
- Diseases
- Glaucoma
- NCT number
- NCT05247762
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 28 Feb 2022 to the primary completion date, 30 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Laser surgery for either glaucoma or myopia.
Other illness
- Comorbidity with other chronic diseases, such as hypertension and diabetes, and taking multiple drugs.
- Allergy to acupuncture needles.
Other
- Pregnancy or lactation.
- Intolerance to acupuncture treatment.
- Refusal to sign the informed consent form.
Who the study is looking for
- Open-angle glaucoma diagnosis at least 3 months previously.
- Use of one or no intraocular hypotensive drugs.
- There is no evidence of other eye diseases other than glaucoma.
- Clear consciousness that enabled the participant to sign the informed consent form and cooperate with the trial procedure.
Age in the registry: 20 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| China Medical University Hospital Coordinator of this site? Confirm its status | Taichung | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.